These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9121326)

  • 1. Leucocytopenia after rifampicin and ofloxacin therapy in leprosy.
    Vijayakumaran P; Manimozhi N; Jesudasan K; Arunthathi S; Jacob M; Samuel P
    Lepr Rev; 1997 Mar; 68(1):10-5. PubMed ID: 9121326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic prospects for paucibacillary leprosy.
    Katoch K
    Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
    [No Abstract]   [Full Text] [Related]  

  • 4. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse in a borderline-tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy.
    Shetty VP; Antia NH
    Lepr Rev; 1997 Jun; 68(2):162-6. PubMed ID: 9217356
    [No Abstract]   [Full Text] [Related]  

  • 6. "Flu" syndrome on monthly rifampin dose; first case reported from Yemen.
    al-Samie AR; al-Qubati Y
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):574-6. PubMed ID: 8642225
    [No Abstract]   [Full Text] [Related]  

  • 7. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation years in leprosy patients treated with single dose alternative scheme ROM (rifampin, ofloxacin, minocycline), after seven to nine].
    Diniz LM; Catabriga MD; Souza Filho JB
    Rev Soc Bras Med Trop; 2010; 43(6):695-9. PubMed ID: 21181026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone syndrome: an incomplete form.
    Jaswal R; Thami GP; Kanwar AJ
    Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
    [No Abstract]   [Full Text] [Related]  

  • 10. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
    Sehgal VN; Kumar S; Jain S; Bhattacharya SN
    J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
    [No Abstract]   [Full Text] [Related]  

  • 11. A recurrent case of BT leprosy with widely spread skin lesions showing a histopathology of indeterminate group after 4.5-years irregular treatment, Bangladesh.
    Ishida Y; Ozaki M; Picorini L; Guglielmelli E
    Nihon Hansenbyo Gakkai Zasshi; 1999 Nov; 68(3):195-9. PubMed ID: 10659615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute renal failure and hepatitis induced by intermittent rifampicin therapy.
    Pandey VP; Taneja S; Talati R
    J Assoc Physicians India; 1999 Aug; 47(8):837. PubMed ID: 10778640
    [No Abstract]   [Full Text] [Related]  

  • 13. Leprosy in a preschool child--a case report.
    Arora SK
    J Indian Med Assoc; 2007 Mar; 105(3):140. PubMed ID: 17824468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 16. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects.
    Gonçalves Hde S; Pontes MA; Bührer-Sékula S; Cruz R; Almeida PC; Moraes ME; Penna GO
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():74-8. PubMed ID: 23283457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of post-partum borderline tuberculoid leprosy complicated by a median nerve abscess, peptic ulceration and rifampicin-induced haemolytic renal failure.
    Dawe S; Lockwood DN; Creamer D
    Lepr Rev; 2004 Jun; 75(2):181-7. PubMed ID: 15282971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S; Reddy R
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract]   [Full Text] [Related]  

  • 20. Problems of multidrug therapy.
    Ramu G
    Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.